SecBot SecBot
PRESS-RELEASE ·Filed Apr 17, 2026

RPRX

Royalty Pharma plc
NEUTRAL
Impact 3/10
Horizonimmediate Processed7mo ago WireGlobeNewswire
Press release · Dividend
Actionable Insight • Neutral

This is a routine dividend; no strategic shift or financial change is indicated. Traders should monitor for any future adjustments in payout ratio or yield signaling a policy shift.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$50.00
T+0 close · Apr 17, 2026 · via day close
Latest settled
+11.34%
T+60 · $55.67
Vs SPY
+5.20%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 17 $50.00entry
  2. T+1 · 7mo ago −1.40%α −1.21% · $49.30
  3. T+5 · 7mo ago −1.24%α −1.79% · $49.38
  4. T+20 · 6mo ago +6.80%α +1.43% · $53.40
  5. T+60 · 4mo ago +11.34%α +5.20% · $55.67
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Royalty Pharma announced a quarterly dividend of $0.235 per share, payable June 10, 2026, to shareholders of record as of May 15, 2026. This is a routine capital return with no change in dividend policy or magnitude.

Key Facts

  • Royalty Pharma declared a quarterly dividend of $0.235 per Class A ordinary share.
  • Dividend payable on June 10, 2026, to shareholders of record on May 15, 2026.
  • No change in dividend amount or policy announced.

Financial Impact

Approximately $138 million quarterly (based on ~587 million shares outstanding and $28B market cap)

dividendcash outflow

Risk Factors

  • Ongoing insider selling ($1.6M in the last 30 days) may signal muted confidence despite stable dividends.
  • Pharma royalty models are sensitive to drug lifecycle risk and patent expirations, though not reflected in this filing.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3276138

Track record

23 reports on RPRX

Performance horizon

5 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +15.20% at T+60 after the May 6, 2026 report. 5 of 5 went positive at some point.

Filters
  1. Nov 16, 2026today 144 Neutral 2/10 Entry price pending
  2. Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $67.57 to $68.97 Now $68.53 +1.41% ▲ +2.07% −1.22% vs SPY
  3. Nov 4, 202612d ago 8-K Neutral 5/10 No price data
  4. Nov 4, 202612d ago Press Release Bullish 6/10 Entry $67.56 to $70.01 Now $68.53 +1.43% ▲ +3.63% +4.54% vs SPY
  5. Sep 30, 20266w ago Insider Cluster Bearish 5/10 Entry $57.63 to $56.21 Now $68.53 −18.91% ▲ +2.46% +3.77% vs SPY
  6. Sep 4, 202610w ago Press Release Bearish 5/10 Entry $60.59 to $58.47 Now $68.53 −13.10% ▲ +3.50% +2.38% vs SPY
  7. Aug 19, 202612w ago Insider Cluster Neutral 3/10 Entry $60.57 to $61.92 Now $68.53 +13.14% ▲ +2.24% +1.12% vs SPY
  8. Aug 12, 202613w ago 144 Neutral 3/10 Entry $58.56 to $60.58 Now $68.53 +17.02% ▲ +3.45% +5.41% vs SPY
  9. Aug 5, 202614w ago 8-K Bullish 6/10 Entry $57.75 to $59.22 Now $68.53 +18.66% ▲ +2.55% +2.19% vs SPY
  10. Jul 2, 202619w ago Insider Cluster Neutral 2/10 Entry $57.77 to $57.96 Now $68.53 +18.62% ▲ +0.33% −0.60% vs SPY
Showing 10 of 23

US Market Status

Market Closed · Opens Wed (11h 41m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 17, 2026